Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease

Spremljeno u:
Bibliografski detalji
Izdano u:Nephrol Dial Transplant
Glavni autori: Dekkers, Claire C J, Wheeler, David C, Sjöström, C David, Stefansson, Bergur V, Cain, Valerie, Heerspink, Hiddo J L
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Erratum
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031052/
https://ncbi.nlm.nih.gov/pubmed/29762740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy135
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items